EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017, with sales surpassing $250,000. “Our national sales team continues to expand EVIO’s service offerings,” William Waldrop, CEO of EVIO, stated in the news release. “After an impressive 2017, in which we exceeded our own internal projections, we are starting the 2018 fiscal year on the right track. We are eagerly waiting for the upcoming accreditation of our new pesticide equipment. As mentioned in our 8K, the Oregon Environmental Laboratory Accreditation Program (ORELAP) has provided Monday, October 23, 2017 as their on-site assessment date. As soon [as] our accreditation scope is expanded to include full-service pesticides, the company will be able to perform a majority of our testing in-house. This will tremendously improve our gross margins and overall profitability.”
To view the full press release, visit http://cnw.fm/Bw0mi
About EVIO, Inc.
EVIO, Inc. is an Oregon-based life sciences company that provides analytical testing services, management advisory services and scientific research to the legal cannabis and hemp industries. The Company’s EVIO Labs division operates state-of-the-art facilities and offers accredited testing methodologies to ensure the safety and quality of the nation’s cannabis supply. Learn more at www.EvioLabs.com or the Company can be reached directly @ 1-888-544-EVIO.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com